Adjuvant Treatment in Carcinoma of Endometrium: Where Do We Stand?

Authors

  • D. K. Vijay kumar Professor and Head Amrita Institute of Medical Sciences and Research Centre Surgical and Gynaecologic Oncology Amrita Lane, AIMS, Ponekkara Kochi, Kerala.
  • Beena Kunheri Department of Radiation Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidhyapeedham, Coimbatore, Tamil Nadu, India
  • Anand RK Department of Radiation Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidhyapeedham, Coimbatore, Tamil Nadu, India

DOI:

https://doi.org/10.37591/rrjooh.v5i3.1391

Abstract

Endometrial cancer is one of the most common gynecological malignancy worldwide. Though there are a large number of completed prospective and retrospective studies, adjuvant treatment remains poorly defined, mainly due to the heterogeneity in selection criteria, different treatment approaches and  low recurrence rates in good risk early stage disease. This article comprehensively covers the different risk stratification approaches and the current concepts and evidences in tailoring of adjuvant treatment in carcinoma of the endometrium.

 

Keywords: Endometrial cancer, malignancy, endometrium treatment

Cite this Article

Kunheri B, Vijayakumar DK,Anand RK. Adjuvant Treatment in Carcinoma of Endometrium: Where Do We Stand? Research & Reviews: Journal of Oncology and Hematology. 2016; 5(3):       22–29p.

Downloads

Published

2019-04-12

Issue

Vol. 5 No. 3 (2016)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.